Home
About
Overview
Sharing Data
ORCID
Help
History (9)
New Horizons-Addressing Healthcare Disparities in Endocrine Disease: Bias, Science, and Patient Care.
Intracranial multimodal monitoring in neurocritical care (Neurocore-iMMM): an open, decentralized consensus.
Alternative clinical trial design in neurocritical care.
Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.
Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts.
Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts. Biol Psychiatry. 2020 09 15; 88(6):452-458.
View in:
PubMed
subject areas
Adult
Attention Deficit Disorder with Hyperactivity
Central Nervous System Stimulants
Child
Cohort Studies
Female
Humans
Male
Middle Aged
Suicidal Ideation
Suicide, Attempted
United States
authors with profiles
Robert Gibbons